{"id":"W1920830047","doi":"10.1111/dom.12589","title":"Efficacy and safety of canagliflozin when used in conjunction with incretin‐mimetic therapy in patients with type 2 diabetes","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"Novo Nordisk; Medtronic; Sanofi-Aventis Korea Company; Janssen Research and Development; Novartis; Eli Lilly and Company","keywords":"Canagliflozin; Medicine; Placebo; Incretin; Type 2 diabetes; Sitagliptin; Glucagon-like peptide 1 receptor; Internal medicine; Pharmacology; Endocrinology; Adverse effect; Dipeptidyl peptidase-4; Urology; Agonist; Diabetes mellitus; Gastroenterology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003308223,0.0002095466,0.0005826811,0.0002616771,0.00002582557,0.00001784646,0.00004861872,0.00006715291,0.00001194832],"category_scores_gemma":[0.00005085954,0.0001442578,0.0000175435,0.0003107314,0.0001317822,0.0001512998,0.00004137095,0.0001110532,0.000001683445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000350647,"about_ca_system_score_gemma":0.00004825552,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000258759,"about_ca_topic_score_gemma":0.0001722557,"domain_scores_codex":[0.9988586,0.00008485297,0.000226961,0.0002828869,0.0002496151,0.0002971252],"domain_scores_gemma":[0.9993778,0.00006539268,0.00009218755,0.0001965667,0.0001134756,0.000154617],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008107373,0.0005492959,0.9890313,0.00006905934,0.0001790847,0.00000209178,0.0006300297,0.000005444748,0.00009154918,0.00009557781,0.00003395308,0.008501885],"study_design_scores_gemma":[0.01933286,0.001278772,0.9763542,0.0001798919,0.0002087953,6.297492e-8,0.00006893332,0.00003449675,0.0009002206,0.00007974049,0.00140024,0.0001617342],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965313,0.002038367,0.000001163978,0.000104813,0.00005820317,0.0009442758,0.000007033642,0.00002080648,0.0002940139],"genre_scores_gemma":[0.9990466,0.0002174369,0.0003369982,0.0001958702,0.00001961667,0.0000229976,0.00007150628,0.00001960149,0.00006936711],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01852212,"threshold_uncertainty_score":0.5882664,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009532739788251,"score_gpt":0.2029113262920717,"score_spread":0.1933785865038207,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}